Smartwatches and Heart Health: Early Detection and Prevention

Wearable technology is increasingly serving as a tool for precision cardiovascular medicine, providing continuous, noninvasive, and data-driven insights into patient health. Aggregated evidence indicates that these devices can lead to substantial improvements in early detection, remote disease management, and overall patient outcomes.

One of the most critical applications of this technology is the detection of atrial fibrillation (AFib), particularly when the condition is asymptomatic. Asymptomatic AFib is reported to triple the risk of heart failure.

The danger of untreated AFib extends beyond heart failure. According to reports from April 3, 2026, atrial fibrillation—the most common type of irregular heartbeat or arrhythmia—increases the risk of stroke fivefold if it remains untreated.

How Wearables Detect Heart Irregularities

Most smartwatches employ a technology known as photoplethysmography, or PPG, to monitor heart rhythms. This process utilizes lights on the back of the wearable device to detect changes in blood volume.

Dr. Moeen Saleem, an electrophysiologist at the Midwest Cardiovascular Institute, explains that the device uses a photodetector to monitor these changes. Dr. Raffay Khan, a cardiologist and cardiac electrophysiologist at the Chicago Cardiology Institute, notes that when a patient is in atrial fibrillation, they experience changes in blood volume from beat to beat, which the PPG technology can track.

Beyond heart rhythm, smartwatches can monitor various other parameters by measuring body movements and a person’s pulse.

Clinical Applications and Disease Management

The utility of wearable devices extends across the spectrum of cardiovascular care, including risk assessment, prevention, diagnosis, and management. In addition to AFib detection, these tools are being used to help monitor symptoms of heart failure.

Recent developments have also integrated artificial intelligence with wearable hardware. An AI tool has successfully detected structural heart disease in adults using data from a smartwatch.

Research published on November 19, 2025, emphasizes that wearable technology stands at the frontier of cardiovascular health, offering a path toward more personalized and proactive medical interventions.

Limitations and Medical Oversight

While these devices provide valuable data, medical professionals emphasize that they are supplements to, not replacements for, clinical diagnosis. Dr. Khan advises users not to panic when a wearable alerts them to an irregular rhythm, stating that such notifications don’t signify an immediate risk of stroke but rather represent a long-term risk.

The consensus among specialists is that while PPG and other wearable sensors are largely accurate and can inform medical care, they don’t replace medical judgment. Clinical experts stress the importance of discussing any wearable-detected findings with a physician to ensure proper diagnosis and treatment.